title: Vertigo and abacavir.
abstract: Vertigo can cause significant morbidity and make a person unable to perform activities of daily life. A human immunodeficiency virus (HIV)-infected patient experienced vertigo while taking abacavir that resolved immediately on cessation of therapy. The mechanism by which abacavir appeared to be associated with vertigo in this patient is unknown.
authors.affiliation: University of Maryland Medical School; Institute of Human Virology, Baltimore, Maryland, USA. lfantry@medicine.umaryland.edu
authors.forename: Lori E
authors.initials: LE
authors.lastname: Fantry
authors.forename: Hinrich
authors.initials: H
authors.lastname: Staecker
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015224:Dideoxynucleosides / Q000009:adverse effects* / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D008297:Male; D014717:Vertigo / Q000139:chemically induced*; D000099227:Abacavir
chemical_list: D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D000099227:Abacavir